Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019

A group of six cases involving compulsive gambling problems associated with Abilify are being prepared for trial next summer, as part of a “bellwether” process designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the litigation.

There are currently more than 2,000 Abilify gambling cases pending in the federal court system, each involving similar allegations that Bristol-Myers Squibb and Otsuka Pharmaceuticals failed to adequately warn consumers and the medical community that their atypical antipsychotic drug may cause users to experience sudden and uncontrollable urges to gamble or engage in other destructive behaviors.

Plaintiffs each maintain that they could have avoided devastating financial losses and damage to their families if information had been provided about the link between Abilify and gambling addictions, which lawsuits typically indicate emerged shortly after starting use of the drug or changing dosage.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Earlier this year a series of three trials were scheduled, but the parties settled those Abilify cases weeks before they were set to go before juries.

After the drug makers failed to reach a global Abilify settlement structure to resolve large numbers of cases in the litigation, the U.S. District Judge presiding over the litigation selected a second group of cases that were prepared for trial on an expedited basis

In an order (PDF) issued last week, the Court outlined the discovery schedule for six cases selected for a “fast-tracked discovery and trial,” including complaints filed by Bruce Bletz, Licente Harned, Christine Kennedy, Annette Northcutt, Louis Ortiz and Valerie Stingley.

Case specific discovery in the cases will begin in January 2019, and must be completed by March 15, 2019. Expert depositions must then be completed by April 29, with the Court indicating that trials will begin in the Summer of 2019.

The parties are scheduled to meet for a case management conference in late January 2019, and it is expected individual trial dates will be set in a separate order.

While the outcomes of these bellwether cases will not binding on other Abilify gambling claim, if the parties fail to reach an agreement to settle or otherwise resolve the litigation after the trials, large numbers of individual cases may be remanded to U.S. District Courts nationwide for individual trial dates.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges
Novo Nordisk Fails To Warn About Risk of Gastroparesis from Wegovy, Lawsuit Alleges (Posted 2 days ago)

A Wegovy gastroparesis lawsuit filed by a Pennsylvania couple accuses the manufacturer, Novo Nordisk, of failing to provide adequate warnings about the true risks of the injectable weight loss drug.

Lawyers
Lawyers "Optimistic" Suboxone Tolling Agreement Will Be Reached For Tooth Decay Lawsuits (Posted 2 days ago)

Plaintiffs and defendants involved in Suboxone tooth decay lawsuits say they are close to a deal that would allow the filing of federal complaints after some state statue of limitation laws would have disqualified plaintiffs from filing.

Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users
Lawsuit Indicates Tepezza Hearing Impairment Warnings Were Delayed By Horizon Therapeutics, Disregarding Safety of Users (Posted 3 days ago)

New Jersey man indicates he has been left with permanent hearing impairment from Tepezza, alleging that Horizon Therapeutics failed to instruct doctors about the importance of conducting hearing tests on patients using the thyroid eye disease drug.